BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33276254)

  • 1. Protective immunity in swine induced by Porcine Circovirus 2b inactivated vaccines with different antigen payload.
    Guarneri F; Tresoldi ET; Sarli G; Boniotti MB; Lelli D; Barbieri I; Bacci B; D'Annunzio G; Amadori M
    Vet Microbiol; 2021 Jan; 252():108887. PubMed ID: 33276254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of Protection Following Vaccination with Inactivated Porcine Circovirus 2 Vaccines.
    Zanotti C; Martinelli N; Lelli D; Amadori M
    Viral Immunol; 2015 Dec; 28(10):600-8. PubMed ID: 26401584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection.
    Opriessnig T; O'Neill K; Gerber PF; de Castro AM; Gimenéz-Lirola LG; Beach NM; Zhou L; Meng XJ; Wang C; Halbur PG
    Vaccine; 2013 Jan; 31(3):487-94. PubMed ID: 23174198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three commercial one-dose porcine circovirus type 2 (PCV2) vaccines in a herd with concurrent circulation of PCV2b and mutant PCV2b.
    Jeong J; Park C; Choi K; Chae C
    Vet Microbiol; 2015 May; 177(1-2):43-52. PubMed ID: 25790733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
    Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
    Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a porcine circovirus type 2a (PCV2a) vaccine efficacy against experimental PCV2a, PCV2b, and PCV2d challenge.
    Park KH; Oh T; Yang S; Cho H; Kang I; Chae C
    Vet Microbiol; 2019 Apr; 231():87-92. PubMed ID: 30955830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Porcine circovirus type 2b (PCV2b)-based experimental vaccine is effective in the PCV2b-Mycoplasma hyopneumoniae coinfection pig model.
    Opriessnig T; Castro AMMG; Karuppanan AK; Gauger PC; Halbur PG; Matzinger SR; Meng XJ
    Vaccine; 2019 Oct; 37(44):6688-6695. PubMed ID: 31537445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of experimental inactivated and live-attenuated chimeric porcine circovirus (PCV) 1-2b vaccines derived from PCV1 and PCV2b isolates originated in China.
    Li J; Yu T; Wang X; Zhou J; Gao R; Zhang F; Gao X; Gao S; Liu X
    Virol J; 2015 Jul; 12():113. PubMed ID: 26220290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, virological, immunological and pathological evaluation of four porcine circovirus type 2 vaccines.
    Seo HW; Han K; Park C; Chae C
    Vet J; 2014 Apr; 200(1):65-70. PubMed ID: 24618398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivated chimeric porcine circovirus (PCV) 1-2 vaccines based on genotypes 2b and 2d exhibit similar immunological effectiveness in protecting pigs against challenge with PCV2b strain 0233.
    Li J; Yu T; Zhang F; Wang X; Zhou J; Gao X; Gao S; Liu X
    Arch Virol; 2017 Jan; 162(1):235-246. PubMed ID: 27722993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porcine circovirus type 2a or 2b based experimental vaccines provide protection against PCV2d/porcine parvovirus 2 co-challenge.
    Opriessnig T; Karuppannan AK; Halbur PG; Calvert JG; Nitzel GP; Matzinger SR; Meng XJ
    Vaccine; 2020 Feb; 38(8):1975-1981. PubMed ID: 31974016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of sow and/or piglet vaccination of 3 commercial porcine circovirus type 2 (PCV2) single-dose vaccines on pigs under experimental PCV2 challenge.
    Oh Y; Seo HW; Park C; Chae C
    Vet Microbiol; 2014 Aug; 172(3-4):371-80. PubMed ID: 24970364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine.
    Fort M; Sibila M; Nofrarías M; Pérez-Martín E; Olvera A; Mateu E; Segalés J
    Vet Immunol Immunopathol; 2012 Nov; 150(1-2):128-32. PubMed ID: 23010221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of single dose of an inactivated porcine circovirus type 2 (PCV2) whole-virus vaccine with oil adjuvant in piglets.
    Yang K; Li W; Niu H; Yan W; Liu X; Wang Y; Cheng S; Ku X; He Q
    Acta Vet Scand; 2012 Nov; 54(1):67. PubMed ID: 23171757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions.
    Opriessnig T; Xiao CT; Halbur PG; Gerber PF; Matzinger SR; Meng XJ
    Vaccine; 2017 Jan; 35(2):248-254. PubMed ID: 27919634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of porcine circovirus type 2 (PCV2) viremia by a reformulated inactivated chimeric PCV1-2 vaccine-induced humoral and cellular immunity after experimental PCV2 challenge.
    Seo HW; Oh Y; Han K; Park C; Chae C
    BMC Vet Res; 2012 Oct; 8():194. PubMed ID: 23078878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs.
    Fenaux M; Opriessnig T; Halbur PG; Elvinger F; Meng XJ
    J Virol; 2004 Jun; 78(12):6297-303. PubMed ID: 15163723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions.
    Martelli P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Guazzetti S; Caleffi A; Borghetti P
    Vet Microbiol; 2011 May; 149(3-4):339-51. PubMed ID: 21216540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2.
    Opriessnig T; Gerber PF; Xiao CT; Halbur PG; Matzinger SR; Meng XJ
    Vaccine; 2014 Jul; 32(34):4342-8. PubMed ID: 24929119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A live-attenuated chimeric porcine circovirus type 2 (PCV2) vaccine is transmitted to contact pigs but is not upregulated by concurrent infection with porcine parvovirus (PPV) and porcine reproductive and respiratory syndrome virus (PRRSV) and is efficacious in a PCV2b-PRRSV-PPV challenge model.
    Opriessnig T; Shen HG; Pal N; Ramamoorthy S; Huang YW; Lager KM; Beach NM; Halbur PG; Meng XJ
    Clin Vaccine Immunol; 2011 Aug; 18(8):1261-8. PubMed ID: 21653745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.